{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:34:26Z","timestamp":1791477266845,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd001533.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000}}],"reference-count":157,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001533.pub6","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T15:33:01Z","timestamp":1599492781000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Corticosteroid therapy for nephrotic syndrome in children"],"prefix":"10.1002","author":[{"given":"Deirdre","family":"Hahn","sequence":"additional","affiliation":[{"name":"Department of Nephrology; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Samuel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; University of Calgary; Calgary Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narelle S","family":"Willis","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"},{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"},{"name":"College of Medicine and Public Health; Flinders University; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Hodson","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"},{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/adc.2007.116079","article-title":"Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial","volume":"93","author":"Abeyagunawardena","year":"2008","journal-title":"Archives of Disease in Childhood"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0002|cit2","first-page":"1689","article-title":"A short course of prednisolone during an upper respiratory tract infection reduces the risk of relapse in childhood nephrotic syndrome [abstract no: P12]","volume":"29","author":"Abeyagunawardena","year":"2014","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00467-017-3640-5","article-title":"Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome","volume":"32","author":"Abeyagunawardena","year":"2017","journal-title":"Pediatric Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001533.pub6-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"A155","DOI":"10.1136\/archdischild-2014-306237.358","article-title":"Short course of daily prednisolone during upper respiratory tract infection reduces the risk of relapse in childhood nephrotic syndrome [abstract no: G376(P)]","volume":"99","author":"Abeyagunawardena","year":"2014","journal-title":"Archives of Disease in Childhood"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0005|cit5","first-page":"1906","article-title":"Open randomized clinical study to evaluate efficacy and safety of deflazacort versus prednisolone in idiopathic nephrotic syndrome [abstract no: 558]","volume":"25","author":"Agarwal","year":"2010","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpam.2017.12.004","article-title":"A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center","volume":"5","author":"Al Talhi","year":"2018","journal-title":"International Journal of Pediatrics & Adolescent Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0007|cit7","first-page":"1609","article-title":"Standard versus long term corticosteroid therapy in the treatment of initial episode of nephrotic syndrome in children [abstract no: P-SUN228]","volume":"28","author":"Anand","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00442096","article-title":"Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. A report of \"Arbeitsgemeinschaft fur Padiatrische Nephrologie\"","volume":"135","year":"1981","journal-title":"European Journal of Pediatrics"},{"issue":"8113","key":"10.1002\/14651858.CD001533.pub6-BIB0009|cit9","first-page":"401","article-title":"Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of \"Arbetsgemeinschaft fur Padiatrische Nephrologie\"","volume":"1","year":"1979","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0010|cit10","first-page":"210","volume-title":"Glomerulonephritis. International Conference on Pathogenesis, Pathology and Treatment","author":"Brodehl","year":"1977"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2008-1033800","article-title":"The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft fur Padiatrische Nephrologie (APN)","volume":"194","author":"Brodehl","year":"1982","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0012|cit12","unstructured":"Ehrich JH Initial treatment of idiopathic nephrotic syndrome: short vs standard prednisone [abstract] 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK 1987 59"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0013|cit13","first-page":"C28","article-title":"Short initial prednisone therapy versus standard prednisone therapy in the steroid responsive nephrotic syndrome [abstract no: F5-1]","volume":"1","author":"Ehrich","year":"1987","journal-title":"Pediatric Nephrology"},{"issue":"8582","key":"10.1002\/14651858.CD001533.pub6-BIB0014|cit14","first-page":"380","article-title":"Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie","volume":"1","year":"1988","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0015|cit15","first-page":"771","article-title":"Minimal change nephrotic syndrome: long prednisone therapy vs standard prednisone therapy [abstract]","volume":"6","author":"Ehrich","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01956754","article-title":"Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie","volume":"152","author":"Ehrich","year":"1993","journal-title":"European Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0017|cit17","first-page":"C155","article-title":"Long (LP) versus standard (SP) initial prednisolone treatment for idiopathic nephrotic syndrome (NS) [abstract no: P225]","volume":"12","author":"Bagga","year":"1998","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0018|cit18","unstructured":"Bagga A Hari P Srivastava RN Long (LP) versus standard (SP) initial prednisolone treatment for nephrotic syndrome (NS) [abstract no: FP23] 3rd Congress. Nephrology Urology Transplantation Society (NUTS) of SAARC; 1999 Feb 18 - 21; Colombo, Sri Lanka 1999 158"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004670050708","article-title":"Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome","volume":"13","author":"Bagga","year":"1999","journal-title":"Pediatric Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD001533.pub6-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10157-020-01875-y","article-title":"Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome","volume":"24","author":"Basu","year":"2020","journal-title":"Clinical & Experimental Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00431-019-03506-5","article-title":"Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study","volume":"179","author":"Borovitz","year":"2020","journal-title":"European Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0022|cit22","first-page":"1647","article-title":"Lower prednisone dosing for nephrotic syndrome relapse: a prospective randomized study [abstract no: O-07]","volume":"32","author":"Borovitz","year":"2017","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0023|cit23","first-page":"414","article-title":"A randomized double blind study of deflazacort (D) versus prednisone (P) in the treatment of idiopathic nephrotic syndrome (INS) [abstract no: 1548]","volume":"6","author":"Broyer","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s004670050308","article-title":"A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome","volume":"11","author":"Broyer","year":"1997","journal-title":"Pediatric Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0025|cit25","first-page":"A113","article-title":"Single versus divided dose prednisolone therapy for relapses of nephrotic syndrome (NS) [abstract]","volume":"12","author":"Bagga","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s004670050344","article-title":"Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome","volume":"11","author":"Ekka","year":"1997","journal-title":"Pediatric Nephrology"},{"issue":"7 Suppl 1","key":"10.1002\/14651858.CD001533.pub6-BIB0027|cit27","first-page":"S158","article-title":"Administration of daily corticosteroids prevents infection-associated relapses in frequently relapsing NS [abstract]","volume":"74","author":"Gulati","year":"2010","journal-title":"Clinical Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0028|cit28","unstructured":"Gulati A Math A Sreeniwas V Hari P Bagga A Administration of daily corticosteroids prevents infection associated relapses in frequently relapsing nephrotic syndrome [abstract no: SU714] World Congress of Nephrology; 2009 May 22-26; Milan, Italy 2009"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0029|cit29","first-page":"1874","article-title":"Efficacy of daily corticosteroids to prevent infection associated relapses in frequently relapsing nephrotic syndrome: A randomized controlled trial [abstract]","volume":"25","author":"Gulati","year":"2010","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.01850310","article-title":"Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Gulati","year":"2011","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0031|cit31","first-page":"1335","article-title":"Low versus standard dosage of prednisolone for initial treatment of idiopathic nephrotic syndrome in children [abstract no: A0445]","volume":"7","author":"Hiraoka","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1046\/j.1523-1755.2000.00279.x","article-title":"Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children","volume":"58","author":"Hiraoka","year":"2000","journal-title":"Kidney International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD001533.pub6-BIB0033|cit33","first-page":"103A","article-title":"Older boys benefit from intensive initial prednisolone therapy for nephrotic syndrome [abstract]","volume":"10","author":"Hiraoka","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD001533.pub6-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(03)00346-9","article-title":"A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children","volume":"41","author":"Hiraoka","year":"2003","journal-title":"American Journal of Kidney Diseases"},{"issue":"6505","key":"10.1002\/14651858.CD001533.pub6-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/bmj.291.6505.1305","article-title":"Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome","volume":"291","author":"Imbasciati","year":"1985","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0036|cit36","first-page":"239","article-title":"Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the International Study of Kidney Disease in Children","volume":"95","year":"1979","journal-title":"Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0037|cit37","first-page":"C81","article-title":"Comparison of ISKDC regime with a 7 months steroid regime in the first attack of nephrotic syndrome [abstract no: OPFC26]","volume":"19","author":"Jayantha","year":"2004","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0038|cit38","unstructured":"Jayantha UK Comparison of ISKDC regime with a six month steroid regime in the treatment of steroid sensitive nephrotic syndrome Data on file 2002"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0039|cit39","unstructured":"Jayantha UK Comparison of ISKDC regime with a six month steroid regime in the treatment of steroid sensitive nephrotic syndrome [abstract no: FP2B] 7th Asian Congress of Pediatric Nephrology; 2000 Nov 1-4; Singapore 2000 28"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0040|cit40","unstructured":"Jayantha UK Comparison of ISKDC regime with 6 month regime in patients with relapsing nephrotic syndrome Data on file 2002"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0041|cit41","first-page":"C99","article-title":"Prolong versus standard steroid therapy for children with relapsing course of nephrotic syndrome [abstract no: P026]","volume":"19","author":"Jayantha","year":"2004","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0042|cit42","first-page":"1871","article-title":"Effectiveness of a low dose prednisolone regimen for treatment of relapses in children with SSNS [abstract no: IPN10471- 84]","volume":"34","author":"Kansal","year":"2019","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0043|cit43","first-page":"45","article-title":"Comparison of short and long treatment at onset of steroid sensitive nephrosis (SSN). Preliminary results of a multicenter controlled trial for the French Society of Pediatric Nephrology [abstract]","volume":"3","author":"Kleinknecht","year":"1982","journal-title":"International Journal of Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1651-2227.1995.tb13787.x","article-title":"Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children","volume":"84","author":"Ksiazek","year":"1995","journal-title":"Acta Paediatrica"},{"issue":"6117","key":"10.1002\/14651858.CD001533.pub6-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bmj.1.6117.892","article-title":"Idiopathic nephrotic syndrome: prevention of early relapse","volume":"1","author":"Leisti","year":"1978","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0046|cit46","first-page":"386","article-title":"Treatment of children with simple nephrotic syndrom using prednison once per day","volume":"15","author":"Li","year":"1994","journal-title":"Acta Academiae Medicinae Hubei"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0047|cit47","first-page":"563","article-title":"Recovery of total immunoglobulin and immunoglobulin subclasses in nephrotic syndrome: deflazacort vs methylprednisone","volume":"28","author":"Liern","year":"2008","journal-title":"Nefrologia"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000045684","article-title":"Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome","volume":"85","author":"Mattoo","year":"2000","journal-title":"Nephron"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5301\/jn.5000016","article-title":"Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome","volume":"25","author":"Mishra","year":"2012","journal-title":"Journal of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02761198","article-title":"High dose methylprednisolone therapy in nephrotic syndrome","volume":"66","author":"Mocan","year":"1999","journal-title":"Indian Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0051|cit51","first-page":"A74","article-title":"The effect of high dose methylprednisolone therapy in patients with minimal change nephrotic syndrome [abstract]","volume":"12","author":"Mocan","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0052|cit52","first-page":"212","article-title":"Management of nephrotic syndrome: ISKDC versus APN","volume":"6","author":"Moundekhel","year":"2012","journal-title":"Pakistan Journal of Medical & Health Sciences"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0053|cit53","first-page":"567","article-title":"Initial therapy of primary nephrotic syndrome in children: evaluation in a period of 18 months of two prednisone treatment schedules. Chilean Co-operative Group of Study of Nephrotic Syndrome in Children","volume":"124","author":"Norero","year":"1996","journal-title":"Revista Medica de Chile"},{"issue":"6","key":"10.1002\/14651858.CD001533.pub6-BIB0054|cit54","first-page":"C88","article-title":"Long term evaluation of two prednisone treatments in initial idiopathic nephrotic syndrome (INS) in children. Preliminary findings [abstract no: P135]","volume":"9","author":"Norero","year":"1995","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0055|cit55","first-page":"261","article-title":"Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome","volume":"23","author":"Paul","year":"2014","journal-title":"Mymensingh Medical Journal: MMJ"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD001533.pub6-BIB0056|cit56","first-page":"v230","article-title":"Therapy of first episode steroid responsive nephrotic syndrome (FESRNS): a randomised controlled trial [abstract no: MP087]","volume":"20","author":"Pecoraro","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0057|cit57","first-page":"C72","article-title":"Therapy of first episode of steroid responsive nephrotic syndrome: a randomised controlled trial [abstract no: OFC41]","volume":"19","author":"Pecoraro","year":"2004","journal-title":"Pediatric Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001533.pub6-BIB0058|cit58","first-page":"63","article-title":"Therapy of first episode of steroid responsive nephrotic syndrome: a randomised controlled trial [abstract no: M199]","volume":"18","author":"Pecoraro","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0059|cit59","unstructured":"Webb N Trompeter R Cummins C Wheatley K Frew E Long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome: national multicentre randomised double blind trial [protocol] PREDNOS Clinical Trial Protocol Version 2.1"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0060|cit60","first-page":"1647","article-title":"Standard vs extended course prednisolone therapy for the presenting episode of steroid sensitive nephrotic syndrome: the PREDNOS study [abstract no: O-08]","volume":"32","author":"Webb","year":"2017","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"l1800","DOI":"10.1136\/bmj.l1800","article-title":"Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation","volume":"365","author":"Webb","year":"2019","journal-title":"BMJ"},{"issue":"26","key":"10.1002\/14651858.CD001533.pub6-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23260","article-title":"Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT","volume":"23","author":"Webb","year":"2019","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"26","key":"10.1002\/14651858.CD001533.pub6-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23260","article-title":"Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT","volume":"23","author":"Webb","year":"2019","journal-title":"Health Technology Assessment (Winchester, England)"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0064|cit64","first-page":"1810","article-title":"Short versus long courses of prednisone for the treatment of relapses of steroid sensitive nephrotic syndrome. results of the PROPINE study [abstract no: O-4]","volume":"33","author":"Gargiulo","year":"2018","journal-title":"Pediatric Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00467-015-3285-1","article-title":"Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial","volume":"31","author":"Raman","year":"2016","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0066|cit66","first-page":"C117","article-title":"Standard vs low initial dose of prednisolone therapy for first episodes of nephrotic syndrome in children [abstract no: P238]","volume":"16","author":"Satomura","year":"2001","journal-title":"Pediatric Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD001533.pub6-BIB0067|cit67","first-page":"A87","article-title":"Comparison of abrupt withdrawal versus slow tapering regimen of prednisolone therapy in the management of first episode of steroid responsive childhood idiopathic nephrotic syndrome [abstract]","volume":"16","author":"Gulati","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0068|cit68","unstructured":"Sharma RK Ahmed M Gulati S Gupta A Pokhariyal S Comparison of abrupt withdrawal versus slow tapering regimen of prednisolone therapy in the management of first episode of steroid responsive childhood idiopathic nephrotic syndrome Data on file 2002"},{"issue":"Sept","key":"10.1002\/14651858.CD001533.pub6-BIB0069|cit69","first-page":"97A","article-title":"Comparison of abrupt withdrawal versus slow tapering regimens of prednisolone therapy in management of first episode of steroid responsive childhood idiopathic nephrotic syndrome [abstract]","volume":"11","author":"Sharma","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0070|cit70","first-page":"1980","article-title":"Low versus conventional dose prednisolone for nephrotic syndrome relapses: randomised-controlled, non-inferiority-trial [abstract no: IPN10923-86]","volume":"34","author":"Sheikh","year":"2019","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.5812\/ijp.510","article-title":"Deflazacort versus prednisolone: randomized controlled trial in treatment of children with idiopathic nephrotic syndrome","volume":"25","author":"Singhal","year":"2015","journal-title":"Iranian Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0072|cit72","first-page":"1707","article-title":"Randomized double blind, placebo controlled trial to compare the efficacy of 3-months versus 6-months therapy with prednisolone for the first episode of idiopathic nephrotic syndrome (CTRI\/2010\/091\/001095) [abstract no: P139]","volume":"27","author":"Bagga","year":"2012","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0073|cit73","first-page":"1361","article-title":"Randomized, double blind, placebo controlled trial to compare the efficacy of 3-months versus 6-months therapy with prednisolone for the first episode of idiopathic nephritic syndrome [abstract no: O-40]","volume":"28","author":"Sinha","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid- sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/FTD.0000000000000308","article-title":"Population pharmacokinetics of prednisolone in relation to clinical outcome in children with nephrotic syndrome","volume":"38","author":"Teeninga","year":"2016","journal-title":"Therapeutic Drug Monitoring"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0076|cit76","first-page":"1884","article-title":"Optimal treatment of steroid sensitive nephrotic syndrome in children: a multicenter randomised controlled trial [abstract no: 450]","volume":"25","author":"Teeninga","year":"2010","journal-title":"Pediatric Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0077|cit77","first-page":"1619","article-title":"Optimal treatment of steroid sensitive nephrotic syndrome in children: a randomised controlled trial [abstract no: P090]","volume":"23","author":"Teeninga","year":"2008","journal-title":"Pediatric Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD001533.pub6-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/ki.2013.531","article-title":"Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome","volume":"85","author":"Teeninga","year":"2014","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0080|cit80","first-page":"1637","article-title":"Effect of extended prednisolone treatment from three to six months, with equal cumulative doses, on childhood nephrotic syndrome: a nation-wide randomised controlled trial [abstract no: OP61]","volume":"27","author":"Teeninga","year":"2012","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0022-3476(88)80136-7","article-title":"Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome","volume":"112","author":"Ueda","year":"1988","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0082|cit82","unstructured":"Ueda N Chihara M Kawaguchi S Niinomi Y Yasaki T Intermittent versus long-term tapering prednisolone regimens as initial therapy in children with steroid-responsive nephrotic syndrome. [abstract] 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK 1987 98"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0083|cit83","first-page":"1752","article-title":"Efficacy of low-dose daily versus alternate day prednisone in children with frequently relapsing nephrotic syndrome (FRNS): open-label randomized controlled trial (RCT) [abstract no: FP-S25-09]","volume":"31","author":"Yadav","year":"2016","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00467-018-4071-7","article-title":"Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"34","author":"Yadav","year":"2019","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0085|cit85","unstructured":"Ito H Yoshikawa N Multicenter controlled trial in nephrotic syndrome in Japanese children [abstract no: S-13.5] 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 - Sep 4; Jerusalem, Israel 1992 C37"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2215\/CJN.09010912","article-title":"Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome","volume":"8","author":"Nakanishi","year":"2013","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0087|cit87","first-page":"C3","article-title":"Treatment of idiopathic nephrotic syndrome [abstract no: S-1]","volume":"10","author":"Takekoshi","year":"1996","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0088|cit88","first-page":"587","article-title":"Standard versus long-term prednisolone with sairei-to for initial therapy in childhood steroid-responsive nephrotic syndrome: a prospective controlled study","volume":"40","author":"Yoshikawa","year":"1998","journal-title":"Nippon Jinzon Gakkai Shi [Japanese Journal of Nephrology]"},{"issue":"Abstracts","key":"10.1002\/14651858.CD001533.pub6-BIB0089|cit89","first-page":"3B","article-title":"Increased duration and dose of prednisolone (PSL) treatment does not reduce relapses in childhood nephrotic syndrome [abstract no: SA-PO1080]","volume":"24","author":"Yoshikawa","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0091|cit91","first-page":"1609","article-title":"Prospective clinical randomized controlled trial of pulse methylprednisolone therapy in children with steroid sensitive nephrotic syndrome [abstract no: 797 (P)]","volume":"22","author":"Zhang","year":"2007","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0092|cit92","first-page":"C26","article-title":"Results of the nephrotic syndrome study VIII of the APN: new standard treatment versus new standard treatment plus 8 weeks cyclosporin A [abstract]","volume":"13","year":"1999","journal-title":"Pediatric Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1151-7","DOI":"10.1681\/ASN.2005090922","article-title":"Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial","volume":"17","author":"Hoyer","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD001533.pub6-BIB0094|cit94","first-page":"C91","article-title":"The initial treatment of idiopathic nephrotic syndrome with prednisone and cyclosporin A: preliminary results of a therapeutic trial [abstract no: P147]","volume":"9","author":"Hoyer","year":"1995","journal-title":"Pediatric Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD001533.pub6-BIB0095|cit95","first-page":"104A","article-title":"Results of the Nephrotic Syndrome Study VIII of the APN: new standard treatment versus new standard treatment plus 8 weeks cyclosporin A [abstract]","volume":"10","author":"Hoyer","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00431-013-2192-3","article-title":"A prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome","volume":"173","author":"Zhang","year":"2014","journal-title":"European Journal of Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0097|cit97","first-page":"1364","article-title":"A prospective clinical randomized controlled trial on azithromycin therapy in induction treatment in children with nephrotic syndrome [abstract no: O-44]","volume":"28","author":"Zhang","year":"2013","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0098|cit98","unstructured":"Hari P Efficacy of short prednisolone treatment for relapse in children with steroid sensitive nephrotic syndrome: a randomised controlled study www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=12315"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0099|cit99","unstructured":"Kalra S A randomized controlled clinical trial to compare the efficacy of standard dose of steroids vs reduced dose in treating relapses in children with steroid sensitive nephrotic syndrome www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=25815"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0100|cit100","unstructured":"Mishra K A comparison of two doses of prednisolone for relapses in children with steroid sensitive nephrotic syndrome: a randomized controlled non inferiority trial www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=26036"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0101|cit101","first-page":"147","article-title":"Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial","volume":"15","author":"Webb","year":"2014","journal-title":"Trials [Electronic Resource]"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0102|cit102","first-page":"1729","article-title":"Steroid treatment reduction in relapsing childhood nephrotic syndrome: a new nationwide randomized controlled trial in the Netherlands - the RESTERN study [abstract no: P-163]","volume":"32","author":"Schijvens","year":"2017","journal-title":"Pediatric Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"e018148","DOI":"10.1136\/bmjopen-2017-018148","article-title":"REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study","volume":"7","author":"Schijvens","year":"2017","journal-title":"BMJ Open"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0104|cit104","first-page":"2076","article-title":"6-months versus 3-months prednisolone for initial therapy of steroid sensitive nephrotic syndrome: open label RCT [abstract no: IPN11430-80]","volume":"34","author":"Sinha","year":"2019","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0105|cit105","first-page":"1867","article-title":"Randomized controlled trial to compare efficacy of 3-months versus 6-months therapy with prednisolone for the first episode of idiopathic nephrotic syndrome in children <4-yr-old [abstract no: PO-321]","volume":"31","author":"Sinha","year":"2016","journal-title":"Pediatric Nephrology"},{"issue":"6920","key":"10.1002\/14651858.CD001533.pub6-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(56)90474-3","article-title":"Treatment of nephrosis with prednisolone","volume":"270","author":"Arneil","year":"1956","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0031-3955(16)32565-2","article-title":"The nephrotic syndrome","volume":"18","author":"Arneil","year":"1971","journal-title":"Pediatric Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s10157-019-01696-8","article-title":"The long-term outcome of childhood nephrotic syndrome in Germany: a cross sectional study","volume":"23","author":"Aydin","year":"2019","journal-title":"Clinical & Experimental Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001533.pub6-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"i98","DOI":"10.1093\/ndt\/gfw344","article-title":"Learning to live with nephrotic syndrome: experiences of adult patients and parents of children with nephrotic syndrome","volume":"32","author":"Beanlands","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s004670050310","article-title":"Nephrotic syndrome in South African children: changing perspectives over 20 years","volume":"11","author":"Bhimma","year":"1997","journal-title":"Pediatric Nephrology"},{"issue":"9384","key":"10.1002\/14651858.CD001533.pub6-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0112|cit112","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","volume-title":"Systematic Reviews in Health care: Meta-analysis in context","author":"Egger","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD001533.pub6-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ki.2010.485","article-title":"Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life","volume":"79","author":"Gipson","year":"2011","journal-title":"Kidney International"},{"issue":"7650","key":"10.1002\/14651858.CD001533.pub6-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"F845","DOI":"10.1152\/ajprenal.00161.2010","article-title":"Dose- and time-dependent glucocorticoid receptor signaling in podocytes","volume":"299","author":"Guess","year":"2010","journal-title":"American Journal of Physiology - Renal Physiology"},{"issue":"7414","key":"10.1002\/14651858.CD001533.pub6-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0119|cit119","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000010.pub3","article-title":"Grey literature in meta-analysis of randomized trials of health care interventions","author":"Hopewell","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(88)80260-9","article-title":"Corticosteroids and growth","volume":"113","author":"Hyams","year":"1988","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0122|cit122","first-page":"203","article-title":"Management of steroid sensitive nephrotic syndrome: revised guidelines","volume":"45","author":"Bagga","year":"2008","journal-title":"Indian Pediatrics"},{"issue":"7654","key":"10.1002\/14651858.CD001533.pub6-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(70)91093-7","article-title":"Controlled trial of azathioprine in children with nephrotic syndrome: A report for the International Study of Kidney Disease in Children","volume":"1","author":"Abramowicz","year":"1970","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1542\/peds.73.4.497","article-title":"Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children","volume":"73","year":"1984","journal-title":"Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD001533.pub6-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signaling in health and disease","volume":"34","author":"Kadmiel","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1523-1755.2005.00524.x","article-title":"High incidence of initial and late steroid resistance in childhood nephrotic syndrome","volume":"68","author":"Kim","year":"2005","journal-title":"Kidney International"},{"issue":"7","key":"10.1002\/14651858.CD001533.pub6-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cell.2014.04.038","article-title":"Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaparone cycles","volume":"157","author":"Kirschke","year":"2014","journal-title":"Cell"},{"issue":"7","key":"10.1002\/14651858.CD001533.pub6-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/adc.57.7.544","article-title":"Long-term outcome of primary nephrotic syndrome","volume":"57","author":"Koskimies","year":"1982","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0131|cit131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002290.pub5","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","author":"Larkins","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD001533.pub6-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00467-009-1282-y","article-title":"Management patterns of childhood-onset nephrotic syndrome","volume":"24","author":"MacHardy","year":"2009","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/ndt\/gfq097","article-title":"Behavioural abnormalities in children with nephrotic syndrome","volume":"25","author":"Mishra","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9128","key":"10.1002\/14651858.CD001533.pub6-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"15","key":"10.1002\/14651858.CD001533.pub6-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1001\/jama.285.15.1992","article-title":"Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD001533.pub6-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/ndt\/gfq358","article-title":"Behavioural abnormalities in children with nephrotic syndrome--an underappreciated complication of a standard treatment?","volume":"25","author":"Neuhaus","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1442-9071.2001.00426.x","article-title":"Ocular complications of paediatric patients with nephrotic syndrome","volume":"29","author":"Ng","year":"2001","journal-title":"Clinical & Experimental Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD001533.pub6-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2215\/CJN.05950809","article-title":"Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome","volume":"4","author":"Niaudet","year":"2009","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"10141","key":"10.1002\/14651858.CD001533.pub6-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10157-011-0479-0","article-title":"Dexamethasone increases the phosphorylation of nephrin in cultured podocytes","volume":"15","author":"Ohashi","year":"2011","journal-title":"Clinical & Experimental Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2215\/CJN.12991117","article-title":"Glucocorticoids in the treatment of glomerular diseases","volume":"13","author":"Ponticelli","year":"2018","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00467-016-3458-6","article-title":"Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children","volume":"32","author":"Raja","year":"2017","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheumatic Diseases Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","article-title":"Children with steroid sensitive nephrotic syndrome come of age: long-term outcome","volume":"147","author":"R\u00fcth","year":"2005","journal-title":"Journal of Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD001533.pub6-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00467-013-2546-0","article-title":"Substantial practice variation exists in the management of childhood nephrotic syndrome","volume":"28","author":"Samuel","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-018-3929-z","article-title":"Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome","volume":"34","author":"Schijvens","year":"2019","journal-title":"Pediatric Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0148|cit148","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001533.pub6-BIB0149|cit149","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD001533.pub6-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001533.pub5","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hahn","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/adc.83.1.45","article-title":"Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials","volume":"83","author":"Hodson","year":"2000","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD001533.pub6-BIB0154|cit154","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001533.pub6-BIB0155|cit155","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001533.pub2","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001533.pub6-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001533.pub3","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001533.pub6-BIB0157|cit157","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001533.pub4","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hodson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001533.pub7","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T03:32:24Z","timestamp":1668655944000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001533.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":157,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001533.pub6","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001533.pub7","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]}}}